Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Okuno SH"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-18 z 18
    Tytuł:
    A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
    Autorzy:
    Attia S; Mayo Clinic Jacksonville, Jacksonville, Florida, USA.
    Bolejack V; Cancer Research and Biostatistics, Seattle, Washington, USA.
    Ganjoo KN; Stanford Cancer Institute, Stanford, California, USA.
    George S; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts, USA.
    Agulnik M; City of Hope, Duarte, California, USA.
    Rushing D; Indiana University, Bloomington, Indiana, USA.
    Loggers ET; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
    Livingston MB; Levine Cancer Institute, Charlotte, North Carolina, USA.
    Wright J; Huntsman Cancer Institute, Salt Lake City, Utah, USA.; Lilly Pharmaceuticals, Indianapolis, Indiana, USA.
    Chawla SP; Sarcoma Oncology Center, Santa Monica, California, USA.
    Okuno SH; Mayo Clinic, Rochester, Minnesota, USA.
    Reinke DK; Sarcoma Alliance for Research through Collaboration, Ann Arbor, Michigan, USA.
    Riedel RF; Duke Cancer Institute, Durham, North Carolina, USA.
    Davis LE; Oregon Health & Science University, Portland, Oregon, USA.
    Ryan CW; Oregon Health & Science University, Portland, Oregon, USA.
    Maki RG; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (2), pp. 1532-1539. Date of Electronic Publication: 2022 Aug 10.
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Sarcoma, Ewing*/drug therapy
    Sarcoma*/drug therapy
    Bone Neoplasms*/drug therapy
    Bone Neoplasms*/pathology
    Hypophosphatemia*/chemically induced
    Humans ; Female ; Adult ; Infant ; Male ; Phenylurea Compounds/adverse effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States.
    Autorzy:
    Pollack SM; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
    Somaiah N; MD Anderson Cancer Center, Houston, TX, USA.
    Araujo DM; MD Anderson Cancer Center, Houston, TX, USA.
    Druta M; Moffitt Cancer Center, Tampa, FL, USA.
    Van Tine BA; Washington University Alvin J. Siteman Cancer Center, St. Louis, MO, USA.
    Burgess MA; University of Pittsburgh, Pittsburgh, PA, USA.
    Chawla SP; Sarcoma Oncology Center, Santa Monica, CA, USA.
    Seetharam M; Mayo Clinic, Phoenix, AZ, USA.
    Okuno SH; Mayo Clinic, Rochester, MN, USA.
    Bohac C; Immune Design, South San Francisco, CA, USA.; Macrogenics, Rockville, MD, USA.
    Chen M; Immune Design, South San Francisco, CA, USA.
    Yurasov S; Immune Design, South San Francisco, CA, USA.
    Attia S; Mayo Clinic, Jacksonville, FL, USA.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2020 Jul; Vol. 9 (13), pp. 4593-4602. Date of Electronic Publication: 2020 May 06.
    Typ publikacji:
    Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cancer Care Facilities*
    Antineoplastic Agents/*therapeutic use
    Liposarcoma, Myxoid/*drug therapy
    Sarcoma, Synovial/*drug therapy
    Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Kaplan-Meier Estimate ; Liposarcoma, Myxoid/mortality ; Liposarcoma, Myxoid/pathology ; Liposarcoma, Myxoid/secondary ; Male ; Middle Aged ; Progression-Free Survival ; Regression Analysis ; Retrospective Studies ; Sarcoma, Synovial/mortality ; Sarcoma, Synovial/pathology ; Sarcoma, Synovial/secondary ; Treatment Outcome ; United States ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.
    Autorzy:
    Baird K; Center for Cancer Research, NCI, NIH, Building 10 CRC, Room 1W-3750, MSC 110410 Center Drive, Bethesda, MD 20892-1104, USA.
    Glod J; Center for Cancer Research, NCI, NIH, Building 10-CRC, Room 1-5750, Bethesda, MD 20892-1100, USA.
    Steinberg SM; Center for Cancer Research, NCI, NIH, 9609 Medical Center Drive, Room 2W334, MSC 9716, Bethesda, MD 20892, USA.
    Reinke D; SARC, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106, USA.
    Pressey JG; Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., MLC 7015, Cincinnati, OH 45229, USA.
    Mascarenhas L; Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, 4650 Sunset Boulevard Mail Stop # 54, Los Angeles, CA 90027, USA.
    Federman N; Mattel Children's Hospital, David Geffen School of Medicine, University of California, 10833 Le Conte Avenue, Los Angeles, CA 90095-6901, USA.
    Marina N; Stanford University School of Medicine, Palo Alto, CA 94305, USA.
    Chawla S; Sarcoma Oncology Research Center, 2811 Wilshire Boulevard, Suite 411, Santa Monica, CA 90403, USA.
    Lagmay JP; University of Florida Health Shands Children's Hospital, 1600 SW Archer HD 204, Gainesville, FL 32610, USA.
    Goldberg J; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.
    Milhem M; University of Iowa Hospitals and Clinics, 200 Hawkins Drive C32 GH, Iowa City, IA 52242, USA.
    Loeb DM; Children's Hospital at Montefiore, Albert Einstein College of Medicine, 3411 Wayne Ave., Room 910, Bronx, New York, NY 10467, USA.
    Butrynski JE; Willamette Valley Cancer Institute and Research Center, 520 Country Club Road, Eugene, OR 97401, USA.
    Turpin B; Cincinnati Children's Hospital Medical Center, 3333 Burnett Avenue, Cincinnati, OH 45229, USA.
    Staddon A; Abramson Cancer Center, University of Pennsylvania Health System, 230 W. Washington Square, Philadelphia, PA 19106, USA.
    Spunt SL; Stanford University School of Medicine, 1000 Welch Road Suite 300, MC 5798, Palo Alto, CA 94304, USA.
    Jones RL; The Royal Marsden Hospital and Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK.
    Rodler ET; Comprehensive Cancer Center University of California, Davis, 2279 45th Street, Sacramento, CA 95717, USA.
    Schuetze SM; University of Michigan, 1500 East Medical Center Dr. Ann Arbor, Ann Arbor, MI 48109, USA.
    Okuno SH; Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
    Helman L; Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California Children's Hospital Los Angeles, 4650 Sunset Blvd Mail Stop 57, Los Angeles, CA 90027, USA.
    Pokaż więcej
    Źródło:
    Sarcoma [Sarcoma] 2020 Apr 30; Vol. 2020, pp. 7935475. Date of Electronic Publication: 2020 Apr 30 (Print Publication: 2020).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023).
    Autorzy:
    Kim A; Children's National Medical Center, 111 Michigan Ave., NW, Washington, DC 20010, USA.
    Lu Y; SARC Statistics, Weill Cornell Medicine Healthcare and Policy Research, 602 East 67 Street, New York, NY 10065, USA.
    Okuno SH; Mayo Clinic, 200 First St., SW, Rochester, MN 55905, USA.
    Reinke D; SARC, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48105, USA.
    Maertens O; Children's Hospital of Philadelphia, Univeristy of Pennsylvania, 3501 Civic Center Boulevard, 19104 Philadelphia, PA, USA.
    Perentesis J; Cincinnati Children's Hospital & Uinviersity of Cincinnati, 3333 Burnet Ave., Cincinnati, OH 45229, USA.
    Basu M; Cincinnati Children's Hospital & Uinviersity of Cincinnati, 3333 Burnet Ave., Cincinnati, OH 45229, USA.
    Wolters PL; Pediatric Oncology Branch, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA.
    De Raedt T; Children's Hospital of Philadelphia, Univeristy of Pennsylvania, 3501 Civic Center Boulevard, 19104 Philadelphia, PA, USA.
    Chawla S; Sarcoma Oncology Center, 2811 Wilshire Blvd, Santa Monica, CA 90403, USA.
    Chugh R; University of Michigan, 1500 E. Medical Center Dr., SPC 5912, Ann Arbor, MI 48109, USA.
    Van Tine BA; Washington University in St. Louis, 660 S Euclid Ave., St. Louis, MO 63110, USA.
    O'Sullivan G; National Cancer Institute, Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, Bethesda, MD 20892, USA.
    Chen A; National Cancer Institute, Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, Bethesda, MD 20892, USA.
    Cichowski K; Children's Hospital of Philadelphia, Univeristy of Pennsylvania, 3501 Civic Center Boulevard, 19104 Philadelphia, PA, USA.
    Widemann BC; Pediatric Oncology Branch, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA.
    Pokaż więcej
    Źródło:
    Sarcoma [Sarcoma] 2020 Jan 30; Vol. 2020, pp. 5784876. Date of Electronic Publication: 2020 Jan 30 (Print Publication: 2020).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016).
    Autorzy:
    Widemann BC; National Cancer Institute, Center for Cancer Research, Pediatric Oncology Branch, 10 Center Drive, Building 10, Room 1-3752, Bethesda, MD 20892, USA.
    Lu Y; SARC Statistics, Weill Cornell Medicine Healthcare and Policy Research, 402 East 67th Street, New York, NY 10065, USA.
    Reinke D; SARC, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48105, USA.
    Okuno SH; Mayo Clinic, 200 First St, SW, Rochester, MN 55905, USA.
    Meyer CF; Johns Hopkins Hospital, 1650 Orleans St., CRB1/Room G89, Baltimore, MD 21231, USA.
    Cote GM; Massachusetts General Hospital Cancer Center, Harvard Medical School, 10 North Grove Street, POB-2, Boston, MA 02114, USA.
    Chugh R; University of Michigan, 1500 E. Medical Center Dr, SPC 5912, Ann Arbor, MI 48109, USA.
    Milhem MM; University of Iowa, 200 Hawkins Drive, C32 GH, Iowa, IA 52242, USA.
    Hirbe AC; Washington University of St. Louis, 660 S, Euclid Ave, St. Louis, MO 63110, USA.
    Kim A; Children's National Medical Center, 111 Michigan Ave, NW, Washington, DC 20010, USA.
    Turpin B; Cincinnati Children's Hospital, 3333 Burnet Ave, Cincinnati, OH 45229, USA.
    Pressey JG; Cincinnati Children's Hospital Medical Center, University of Alabama, 1600 7th Avenue South, Lowder 512, Birmingham, AL 35233, USA.
    Dombi E; National Cancer Institute, Center for Cancer Research, Pediatric Oncology Branch, 10 Center Drive, Building 10, Room 1-3752, Bethesda, MD 20892, USA.
    Jayaprakash N; National Cancer Institute, Center for Cancer Research, Pediatric Oncology Branch, 10 Center Drive, Building 10, Room 1-3752, Bethesda, MD 20892, USA.
    Helman LJ; National Cancer Institute, Center for Cancer Research, Pediatric Oncology Branch, 10 Center Drive, Building 10, Room 1-3752, Bethesda, MD 20892, USA.
    Onwudiwe N; SARC, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48105, USA.
    Cichowski K; Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
    Perentesis JP; Cincinnati Children's Hospital, 3333 Burnet Ave, Cincinnati, OH 45229, USA.
    Pokaż więcej
    Źródło:
    Sarcoma [Sarcoma] 2019 Jul 24; Vol. 2019, pp. 7656747. Date of Electronic Publication: 2019 Jul 24 (Print Publication: 2019).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells.
    Autorzy:
    Zuo D; Department of Orthopedic Surgery, 2-69 Medical Sciences, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
    Shogren KL; Department of Orthopedic Surgery, 2-69 Medical Sciences, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
    Zang J; Musculoskeletal Tumor Center, People's Hospital, Peking University, Beijing, 100044, China.
    Jewison DE; Department of Orthopedic Surgery, 2-69 Medical Sciences, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
    Waletzki BE; Department of Orthopedic Surgery, 2-69 Medical Sciences, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
    Miller AL 2nd
    Okuno SH; Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
    Cai Z; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
    Yaszemski MJ; Department of Orthopedic Surgery, 2-69 Medical Sciences, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
    Maran A; Department of Orthopedic Surgery, 2-69 Medical Sciences, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. .
    Pokaż więcej
    Źródło:
    Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2018 Oct 04; Vol. 37 (1), pp. 244. Date of Electronic Publication: 2018 Oct 04.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Benzofurans/*pharmacology
    Bone Neoplasms/*drug therapy
    Naphthoquinones/*pharmacology
    Osteosarcoma/*drug therapy
    STAT3 Transcription Factor/*antagonists & inhibitors
    Animals ; Apoptosis/drug effects ; Bone Neoplasms/metabolism ; Bone Neoplasms/pathology ; Cell Line, Tumor ; Female ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Neoplasm Metastasis ; Osteosarcoma/metabolism ; Osteosarcoma/pathology ; Protein Synthesis Inhibitors/pharmacology ; Random Allocation ; Xenograft Model Antitumor Assays
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing Sarcoma.
    Autorzy:
    Attia S; Mayo Clinic , Jacksonville, FL, USA.
    Okuno SH; Mayo Clinic , Rochester, MN, USA.
    Robinson SI; Mayo Clinic , Rochester, MN, USA.
    Webber NP; 3Aurora Healthcare , Milwaukee, WI, USA.
    Indelicato DJ; 4University of Florida , Jacksonville, FL, USA.
    Jones RL; Royal Marsden Hospital , London, UK.
    Bagaria SP; Royal Marsden Hospital , London, UK.
    Jones RL; Mayo Clinic , Jacksonville, FL, USA.
    Sherman C; Mayo Clinic , Jacksonville, FL, USA.
    Kozak KR; Mercy Medical Center , Janesville, WI, USA.
    Cortese CM; Mayo Clinic , Jacksonville, FL, USA.
    McFarland T; University of Wisconsin , Madison, WI, USA.
    Trent JC; University of Miami , FL, USA.
    Maki RG; Mount Sinai Medical Center , New York, NY, USA.
    Pokaż więcej
    Źródło:
    Rare tumors [Rare Tumors] 2015 May 21; Vol. 7 (2), pp. 5992. Date of Electronic Publication: 2015 May 21 (Print Publication: 2015).
    Typ publikacji:
    Case Reports
    Raport
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Adult ewing sarcoma: survival and local control outcomes in 102 patients with localized disease.
    Autorzy:
    Ahmed SK; Mayo Medical School, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
    Robinson SI
    Okuno SH
    Rose PS
    Laack NN
    Pokaż więcej
    Źródło:
    Sarcoma [Sarcoma] 2013; Vol. 2013, pp. 681425. Date of Electronic Publication: 2013 Jun 11.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas.
    Autorzy:
    von Mehren M; Department of Medical Oncology Fox Chase Cancer Center Philadelphia PA 19111 USA.
    Balcerzak SP
    Kraft AS
    Edmonson JH
    Okuno SH
    Davey M
    McLaughlin S
    Beard MT
    Rogatko A
    Pokaż więcej
    Źródło:
    Sarcoma [Sarcoma] 2004; Vol. 8 (4), pp. 107-11.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-18 z 18

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies